(Q35071350)

6 August 2017

1 reference

title

Intramuscular preparations of antipsychotics: uses and relevance in clinical practice (English)

1 reference

6 August 2017

A Cario Altamura

1

1 reference

6 August 2017

Francesca Sassella

2

1 reference

6 August 2017

Annalisa Santini

3

1 reference

6 August 2017

Clauno Montresor

4

1 reference

6 August 2017

Sara Fumagalli

5

1 reference

6 August 2017

Emanuela Mundo

6

1 reference

6 August 2017

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

63

1 reference

6 August 2017

493-512

1 reference

6 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200363050-00004

6 August 2017

0 references

cites work

Depot pipotiazine 1970-1982: a review

1 reference

12 December 2020

Depot neuroleptics in relapse prevention: advantages and disadvantages.

1 reference

12 December 2020

A clinical trial comparing intramuscular haloperidol decanoate and oral haloperidol in chronic schizophrenic patients: efficacy, safety, and dosage equivalence.

1 reference

12 December 2020

Zuclopenthixol decanoate in maintenance treatment of schizophrenic outpatients. Minimum effective dose and corresponding serum levels

1 reference

12 December 2020

Use of Clopixol Acutard 50 and 100 mg (zuclopenthixol acetate) as a therapeutic drug in crisis at the Cery psychiatric hospital

1 reference

12 December 2020

A double-blind comparison of oral amitriptyline and low-dose intramuscular flupenthixol decanoate in depressive illness.

1 reference

12 December 2020

Perphenazine decanoate vs. perphenazine enanthate: efficacy and side effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients

1 reference

12 December 2020

Emergency treatment of psychotic symptoms. Pharmacokinetic considerations for antipsychotic drugs.

1 reference

12 December 2020

Movement disorders in patients treated with long-acting injectable antipsychotic drugs.

1 reference

12 December 2020

Novel antipsychotics and the problem of clinical stabilization in schizophrenia: are they "stabilizer" rather than typical compounds?

1 reference

12 December 2020

Use of haloperidol decanoate in psychiatric diseases

1 reference

12 December 2020

Prevention of Recidivism of Schizophrenics Treated with Fluphenazine Enanthate

1 reference

12 December 2020

A loading-dose strategy for converting from oral to depot haloperidol

1 reference

12 December 2020

A comparative trial of depot pipothiazine

1 reference

12 December 2020

The role of antipsychotics in treating delirium

1 reference

12 December 2020

[A new injectable delayed-action neuroleptic with sedative and antipsychotic action: cis-(Z)-clopenthixol decanoate. Clinical trials]

1 reference

12 December 2020

Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study

1 reference

12 December 2020

Depot antipsychotic drugs. Place in therapy

1 reference

12 December 2020

The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation

1 reference

12 December 2020

Systematic review of patient and nurse attitudes to depot antipsychotic medication.

1 reference

12 December 2020

Bioavailability of intramuscular versus oral haloperidol in schizophrenic patients

1 reference

12 December 2020

A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia

1 reference

12 December 2020

Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate

1 reference

12 December 2020

Depot fluphenazine in the treatment of psychosis in a community mental health clinic

1 reference

12 December 2020

Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients

1 reference

12 December 2020

Rapid treatment of acute psychotic symptoms with high- and low-dose haloperidol. Behavioral considerations

1 reference

12 December 2020

DISCONTINUATION OR REDUCTION OF CHEMOTHERAPY IN CHRONIC SCHIZOPHRENICS

1 reference

12 December 2020

Fluspirilene in the treatment of non-hospitalized schizophrenic patients

1 reference

12 December 2020

A controlled study of neuroleptization with fluphenazine hydrochloride injections

1 reference

12 December 2020

A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia

1 reference

12 December 2020

Haloperidol for sedation of disruptive emergency patients

1 reference

12 December 2020

Guidelines for depot antipsychotic treatment in schizophrenia

1 reference

12 December 2020

Pharmacokinetics of three different injectable zuclopenthixol preparations

1 reference

12 December 2020

High vs standard dosage fluphenazine HCL in acute schizophrenia

1 reference

12 December 2020

Long-term treatment of chronic schizophrenics with clopenthixol decanoate

1 reference

12 December 2020

12-month study of haloperidol decanoate in chronic schizophrenic patients

1 reference

12 December 2020

A double-blind comparison of fluspirilene and fluphenazine decanoate in schizophrenia

1 reference

12 December 2020

Acute psychopharmacological management of the aggressive psychotic patient

1 reference

12 December 2020

Clinical variables related to suicide attempts in schizophrenic patients: a retrospective study

1 reference

12 December 2020

Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia

1 reference

12 December 2020

A multidimensional (pharmacokinetic and clinical-biological) approach to neuroleptic response in schizophrenia. With particular reference to drug resistance

1 reference

12 December 2020

Large variations of plasma levels during maintenance treatment with depot neuroleptics

1 reference

12 December 2020

A comparative study of pipothiazine palmitate and fluphenazine decanoate in the maintenance of remission of schizophrenia

1 reference

12 December 2020

A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients

1 reference

12 December 2020

Intramuscular haloperidol decanoate for neuroleptic maintenance therapy. Efficacy, dosage schedule and plasma levels. An open multicenter study

1 reference

12 December 2020

Oral versus depot medication in schizophrenia

1 reference

12 December 2020

A 5-year follow-up study of chronic schizophrenics treated with clopenthixol decanoate

1 reference

12 December 2020

Comparative efficacy of long-acting depot and oral neuroleptic medications in preventing schizophrenic recidivism.

1 reference

12 December 2020

Comment on 'reduced haloperidol does not interfere with antipsychotic activity of halperidol in the treatment of acute schizophrenia'

1 reference

12 December 2020

Suicide in Chronic Schizophrenia

1 reference

12 December 2020

Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients

1 reference

12 December 2020

Systematic meta-review of depot antipsychotic drugs for people with schizophrenia

1 reference

12 December 2020

Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial

1 reference

12 December 2020

Ten-year follow-up of schizophrenic patients on pipothiazine palmitate.

1 reference

12 December 2020

Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients

1 reference

12 December 2020

Rapid tranquilization: the efficacy of oral concentrate

1 reference

12 December 2020

Haloperidol dose, plasma levels, and clinical response: a double-blind study [proceedings]

1 reference

12 December 2020

Long-term depot antipsychotics. A risk-benefit assessment

1 reference

12 December 2020

Abscesses following prolonged intramuscular administration of perphenazine enantate

1 reference

12 December 2020

Risperidone in the treatment of negative symptoms of schizophrenia: a meta-analysis

1 reference

12 December 2020

Clonazepam/haloperidol combination therapy in schizophrenia: a double blind study

1 reference

12 December 2020

Short-term inpatient pharmacotherapy of schizophrenia.

1 reference

12 December 2020

Rationalizing neuroleptic polypharmacy in chronic schizophrenics: effects of changing to a single depot preparation

1 reference

12 December 2020

[cis(Z)-Clopenthixol decanoate--a new depot neuroleptic]

1 reference

12 December 2020

Acute psychotic disorders treated with 5% zuclopenthixol acetate in 'Viscoleo' ('Cisordinol-Acutard'), a global assessment of the clinical effect: an open multi-centre study.

1 reference

12 December 2020

Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial

1 reference

12 December 2020

Short-term double-blind trial of pipothiazine palmitate and haloperidol in the acute phase of schizophrenia

1 reference

12 December 2020

A survey of the attitudes of chronic psychiatric patients living in the community toward their medication

1 reference

12 December 2020

A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy

1 reference

12 December 2020

Rapid tranquilization with neuroleptic drugs. Neurologic concerns

1 reference

12 December 2020

Hypothesis testing: is clozapine's superior efficacy dependent on moderate D2 receptor occupancy?

1 reference

12 December 2020

Low- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome

1 reference

12 December 2020

Postdischarge medication compliance of inpatients converted from an oral to a depot neuroleptic regimen

1 reference

12 December 2020

Haloperidol plasma ‘threshold’ levels for relapse prevention in schizophrenia: a study with haloperidol decanoate

1 reference

12 December 2020

Practical considerations in the use of depot neuroleptics for the treatment of schizophrenia

1 reference

12 December 2020

A controlled clinical trial of fluspirilene, a long-acting injectable neuroleptic, in schizophrenic patients with acute exacerbation

1 reference

12 December 2020

Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis

1 reference

12 December 2020

Clinical use of the antipsychotics

1 reference

12 December 2020

A comparative study of the longacting neuroleptics perphenazin-enanthate and fluspirilene (author's transl)

1 reference

12 December 2020

An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.

1 reference

12 December 2020

The suicide rate in schizophrenia

1 reference

12 December 2020

A retrospective evaluation of long-term fluspirilene (IMAP) treatment.

1 reference

12 December 2020

Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation

1 reference

12 December 2020

Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks

1 reference

12 December 2020

Haloperidol decanoate and flupenthixol decanoate in schizophrenia. A long-term double-blind cross-over comparison.

1 reference

12 December 2020

A Double-Blind Controlled Study of Pipothiazine Palmitate in the Maintenance Treatment of Schizophrenic Outpatients

1 reference

12 December 2020

Quality of life and treatment costs in schizophrenic outpatients, treated with depot neuroleptics.

1 reference

12 December 2020

Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation.

1 reference

12 December 2020

The decanoates of flupenthixol and clopenthixol in the treatment of chronic schizophrenic in-patients. Implications for community psychiatry.

1 reference

12 December 2020

Haloperidol decanoate in chronic schizophrenia: a study of 12 months with plasma levels

1 reference

12 December 2020

Long-acting oral vs injectable antipsychotic drugs in schizophrenics: a one-year double-blind comparison in multiple episode schizophrenics

1 reference

12 December 2020

Depot neuroleptic therapy: an underutilized treatment option

1 reference

12 December 2020

A multidose study of haloperidol decanoate in the maintenance treatment of schizophrenia

1 reference

12 December 2020

Perphenazine decanoate in sesame oil vs. perphenazine enanthate in sesame oil: a comparative study of pharmacokinetic properties and some clinical implications

1 reference

12 December 2020

[Experience with fluspirilene in gerontopsychiatry (author's transl)]

1 reference

12 December 2020

Comparison of the effects of pipothiazine palmitate and fluphenazine decanoate. Results of a multicenter double-blind trial

1 reference

12 December 2020

An open clinical trial with the long-acting neuroleptic zuclopenthixol decanoate in the maintenance treatment of schizophrenia.

1 reference

12 December 2020

The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms

1 reference

12 December 2020

Dosing issues and depot medication in the maintenance treatment of schizophrenia.

1 reference

12 December 2020

Efficacy and tolerability of flupenthixol decanoate in the treatment of depression and psychosomatic disorders: a multicenter trial in general practice

1 reference

12 December 2020

Therapeutic efficacy of flupenthixol decanoate in schizoaffective disorder: a clinical evaluation

1 reference

12 December 2020

Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior

1 reference

12 December 2020

Which atypical antipsychotic.

1 reference

12 December 2020

Animal model for investigation of fluphenazine kinetics after administration of long-acting esters

1 reference

12 December 2020

Depot Phenothiazine Treatment in Acute Psychosis: A Sequential Comparative Clinical Study

1 reference

12 December 2020

Pharmacokinetics of haloperidol

1 reference

12 December 2020

Anchoring the BPRS: an aid to improved reliability

1 reference

12 December 2020

Unwanted effects of fluphenazine enanthate and decanoate

1 reference

12 December 2020

The depot fluphenazines: a reappraisal after 10 years' clinical experience

1 reference

12 December 2020

Effect of Haloperidol Dacanoate on the Cardiovascular System

1 reference

12 December 2020

[Positive and negative symptoms in chronic schizophrenic patients under maintenance therapy with flupenthixol decanoate for a twelve month perioid]

1 reference

12 December 2020

Depression-inducing and antidepressive effects of neuroleptics. Experiences with flupenthixol and flupenthixol decanoate

1 reference

12 December 2020

Prediction of response to haloperidol in schizophrenia: neuroendocrine, neuromorphological and clinical variables.

1 reference

12 December 2020

A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania

1 reference

12 December 2020

Duration of neuroleptic treatment and relapse rate: a 5-year follow-up study with haloperidol decanoate

1 reference

12 December 2020

Reduced haloperidol does not interfere with the antipsychotic activity of haloperidol in the treatment of acute schizophrenia

1 reference

12 December 2020

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

1 reference

12 December 2020

Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group.

1 reference

12 December 2020

10.2165/00003495-200363050-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

6 August 2017

0 references

1 reference